BEAVER CAROLYN 4
4 · MEDICINOVA INC · Filed Jun 25, 2026
Research Summary
AI-generated summary of this filing
MediciNova (MNOV) Director Carolyn Beaver Receives Option Award
What Happened
Carolyn Beaver, a director of MediciNova, received a derivative equity award covering 44,500 shares on 2026-06-23. The filing reports an acquisition price of $0.00 and identifies the grant as an option that vests over time rather than an immediate purchase of stock. This is a compensation award rather than a sale.
Key Details
- Transaction date: 2026-06-23; acquisition price reported as $0.00 (derivative award).
- Vesting schedule (Footnote F1): vests in four equal installments on 9/30/2026, 12/31/2026, 3/31/2027 and 6/30/2027, subject to continued service.
- Shares owned after transaction: not specified in the filing.
- Filing date: 2026-06-25 (filed timely; no late filing indicated).
- Transaction type code: A (Grant/Award of derivative securities).
Context
This filing documents an option-style award that will convert into vested equity only as installments vest and, if applicable, are exercised. Awards to directors are commonly part of compensation and do not represent an immediate market purchase or sale.
Insider Transaction Report
Form 4
MEDICINOVA INCMNOV
BEAVER CAROLYN
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-06-23+44,500→ 44,500 totalExercise: $1.36Exp: 2036-06-22→ Common Stock (44,500 underlying)
Footnotes (1)
- [F1]The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company.
Signature
/s/ Yuichi Iwaki, attorney-in-fact|2026-06-25